Sat, Jun 20, 2026 -
Subscribe & never miss our best posts. Subscribe Now!
The L’Oreal Innovist acquisition is here, and no, your moisturiser is not having an existential crisis, but the Indian D2C beauty market certainly is. On June 18, 2026, L’Oréal, the world’s leader in beauty, announced that it had signed an agreement to acquire a majority stake in Innovist, a leading house of personal care brands in India. Think of it as the beauty equivalent of a very polished French aunt deciding she absolutely must have custody of the most talented kids in the family.
Financial details of the transaction were not disclosed because apparently, in the luxury beauty world, talking about money openly is gauche. Earlier media reports, however, suggest the deal could value Innovist somewhere between $350 million and $450 million, which in rupees is roughly ₹4,000 crore, a number that would make most Indian D2C founders choke on their cold brew.
If you’ve ever scrolled through Instagram and seen someone claim their hair “literally came back to life” after switching to Bare Anatomy, you’ve already met Innovist; you just didn’t know it.
Founded in 2018 by Rohit Chawla, Sifat Khurana, and Vimal Bhola, the Gurugram-based company, formerly known as Onesto Labs, operates four brands: Bare Anatomy, Chemist at Play, Sunscoop, and Vinci Botanicals. Science-led, ingredient-transparent, and relentlessly digital-first, Innovist built its entire identity on the premise that Indian consumers deserved better than mystery ingredients buried in tiny font on the back of a shampoo bottle.
Total funding raised by Innovist to date stands at over $30 million, including a $7 million Series A round led by the Amazon Smbhav Venture Fund and a more recent Series B of ₹136 crore led by ICICI Venture. Early investor Accel used the Series B as an exit ramp, which, in hindsight, might be a decision they’re revisiting over a glass of something expensive right now.
Let’s be clear: L’Oréal didn’t come to India for the chai. They came because India’s $5 billion D2C beauty and personal care sector has pulled in over $1 billion in funding between 2014 and mid-2024, and the market is expected to grow into a $28 billion opportunity over the next five years. That is a very large pie, and L’Oréal has decided it would like a very large slice.
This acquisition marks L’Oréal’s first purchase of an Indian company in nearly 13 years, since it bought Mumbai-based Cheryl’s Cosmeceuticals in September 2013. So yes, they’ve been watching. Patiently. Like a very patient, very fragrant hawk.
Under the agreement, Innovist’s founding team will remain in place as minority shareholders and will continue to operate and scale the business in collaboration with L’Oréal India. The Innovist brands will be part of L’Oréal’s Consumer Products Division portfolio. Translation: the founders get to keep their offices, their entrepreneurial pride, and a stake in the company, which is, frankly, a better deal than most startup acquisitions offer.
L’Oréal has also secured the right to buy out the minority shareholders in full at a future date, which means this is less a partnership and more a very elegant, very well-mannered takeover in slow motion.
It would be remiss not to mention the timing. The announcement came a day after Union Commerce and Industry Minister Piyush Goyal met L’Oréal CEO Nicolas Hieronymus on the sidelines of Viva Technology 2026 in Paris. Purely coincidental, of course. Global M&A deals are never accelerated by a friendly ministerial handshake.
Hieronimus himself put the sentiment diplomatically: “Our investment in this innovative Indian start-up is a clear testament to our unwavering commitment to expanding L’Oréal’s footprint in India.” He added that by bringing together L’Oréal’s global expertise with Innovist’s high-performing, science-led products and deep-rooted understanding of the Indian consumer, the company is “poised to shape the future of beauty in this dynamic market.”
Jacques Lebel, Country Manager of L’Oréal India, described India as “one of the most exciting and fast-evolving beauty markets in the world” and said the partnership places the company “right at the heart of that momentum.” One has to admire the restraint in not simply saying, ” We should have done this sooner”.
Let’s zoom out for a moment. India’s D2C beauty space has been a bit like a very crowded room where everyone is shouting about clean ingredients, dermatologist-tested formulas, and “no nasties.” Innovist competes with the likes of Mamaearth, Minimalist, and others, all jostling for the wallet of a consumer who is increasingly informed, increasingly sceptical of marketing fluff, and increasingly willing to pay a premium for something that actually works.
If completed at the upper end of the reported valuation, this transaction would surpass HUL’s acquisition of Minimalist, making it one of the largest deals in India’s D2C beauty segment, which is either fantastic news for the industry or a sign that legacy giants are systematically buying up every interesting homegrown challenger before they get too big to acquire comfortably.
The deal is anticipated to close in the coming months following the usual regulatory and other customary approvals. Until then, your Bare Anatomy serum will continue to arrive in the same minimalist packaging; it just has a very French parent company now.
L’Oreal Innovist Acquisition: French Giant Eyes India
June 19, 2026Noam Shazeer Joins OpenAI After Ditching Google
June 18, 2026
